Esther Rajavelu is Senior Equities Research Analyst, covering biotechnology and specialty pharmaceuticals, at Oppenheimer & Co. Inc. Earlier, she worked at Deutsche and Bank of America Merrill Lynch. She graduated from Wesleyan University and received an MBA from the University of Pennsylvania’s Wharton School.
Election-Related Volatility Creates Good Buying Opportunities
March 20, 2020
